« Notizie

Swissmedic approves Xadago® (safinamide) for use in Parkinson’s Disease

4 Dicembre 2015

Zambon S.p.A., an International Pharmaceutical Company with a strong commitment in central nervous system (CNS) diseases, and its partner Newron Pharmaceuticals S.p.A